HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Excedrin Tension Headache Cooling Pads Five-Month TV Campaign Underway

This article was originally published in The Tan Sheet

Executive Summary

Bristol Myers-Squibb's Excedrin Tension Headache Cooling Pads provide "Quick Cool Comfort," claims a new national TV spot running through August.

You may also be interested in...



Mead Enfamil Sales Buoy Bristol-Myers Nutritionals In Q2

Increased spending on consumer ads and promos for Enfamil infant formula helped the brand post worldwide sales gains of roughly 8% to $172 mil. for the second quarter, Bristol-Myers Squibb's Mead Johnson division said July 25.

Mentholatum Aims To Ice FDA Warning Letter Concerns

The Mentholatum Co. is continuing to sell its Migraine Ice cooling headache pads during ongoing negotiations with FDA regarding the labeling claims for the OTC device. FDA cited unapproved headache and migraine relief claims in an April 18 warning letter to the firm.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS132284

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel